Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2489)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2023 (publication date) through Jun 13, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen YX, Yang P, Du SS, Zhuang Y, Huang C, Hu Y, Zhu WC, Yu YY, Liu TS, Zeng ZC. Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial. World J Gastroenterol 2023; 29(24): 3871-3882 [PMID: 37426321 DOI: 10.3748/wjg.v29.i24.3871] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i24/3871.htm |
| Number | Citing Articles |
| 1 |
Clayton T. Marcinak, Patrick B. Schwartz, Mustafa M. Basree, Newton Hurst, Michael Bassetti, Jeremy D. Kratz, Nataliya V. Uboha. Treatment of Oligometastatic GI Cancers. American Society of Clinical Oncology Educational Book 2024; 44(1) doi: 10.1200/EDBK_430152
|
| 2 |
Seo Hee Choi, Byung min Lee, Jina Kim, Do Young Kim, Jinsil Seong. Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.03.003
|
| 3 |
Zhan Shi, Sihui Zhu, Yuncheng Jin, Liang Qi, Mingzhen Zhou, Ziyan Zhou, Juan Zhang, Baorui Liu, Jie Shen. Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy. Journal of Hepatocellular Carcinoma 2024; : 305 doi: 10.2147/JHC.S452424
|